Who Paid My Doc
Eyp-1901
Drug Wet Age Related Macular Degeneration (wAMD)
General payments
$830,603
Research payments
$6,540,683
Through program year 2024, $830,603 in general payments and $6,540,683 in research payments were reported against Eyp-1901 (Wet Age Related Macular Degeneration (wAMD)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $816,934 | 611 |
| 2024 | Research | $6,540,683 | 140 |
| 2020 | General | $13,669 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 30 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
617 general · 140 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.